{"entity":{"type":"insider","cik":"0001369574","url":"/insider/0001369574","json_url":"/insider/0001369574.json","name":"Thomas, McNerney & Partners II L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":8,"first":"2010-11-29","last":"2022-04-25","span_basis":"filed_date"},"name_variants":[{"name":"Thomas, McNerney & Partners II L.P.","source":"filing","n_filings":8,"first_seen":"2010-11-29","last_seen":"2022-04-25"}],"transactions":[{"id":9219202,"accession":"0001062993-22-010736","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-010736","line_url":"/filing/0001062993-22-010736#line-5","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"Clarus Therapeutics Holdings, Inc.","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS JAMES E; THOMAS MCNERNEY & PARTNERS LP; TMP ASSOCIATES LP; TMP Associates II LP; TMP Nominee II, LLC; TMP Nominee, LLC; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1164.0,"shares_display":"1,164","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":2944.92,"total_display":"2,944.92","shares_owned_after":542.0,"shares_owned_after_display":"542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-25","scope":"insider"},{"id":9219201,"accession":"0001062993-22-010736","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-010736","line_url":"/filing/0001062993-22-010736#line-4","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"Clarus Therapeutics Holdings, Inc.","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS JAMES E; THOMAS MCNERNEY & PARTNERS LP; TMP ASSOCIATES LP; TMP Associates II LP; TMP Nominee II, LLC; TMP Nominee, LLC; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13630.0,"shares_display":"13,630","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":34483.9,"total_display":"34,483.90","shares_owned_after":6340.0,"shares_owned_after_display":"6,340","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-25","scope":"insider"},{"id":9219200,"accession":"0001062993-22-010736","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-010736","line_url":"/filing/0001062993-22-010736#line-3","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"Clarus Therapeutics Holdings, Inc.","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS JAMES E; THOMAS MCNERNEY & PARTNERS LP; TMP ASSOCIATES LP; TMP Associates II LP; TMP Nominee II, LLC; TMP Nominee, LLC; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5722.0,"shares_display":"5,722","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":14476.66,"total_display":"14,476.66","shares_owned_after":2661.0,"shares_owned_after_display":"2,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-25","scope":"insider"},{"id":9219199,"accession":"0001062993-22-010736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-010736","line_url":"/filing/0001062993-22-010736#line-1","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"Clarus Therapeutics Holdings, Inc.","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS JAMES E; THOMAS MCNERNEY & PARTNERS LP; TMP ASSOCIATES LP; TMP Associates II LP; TMP Nominee II, LLC; TMP Nominee, LLC; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1663126.0,"shares_display":"1,663,126","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":4207708.78,"total_display":"4,207,708.78","shares_owned_after":773599.0,"shares_owned_after_display":"773,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-25","scope":"insider"},{"id":9219198,"accession":"0001062993-22-010736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-010736","line_url":"/filing/0001062993-22-010736#line-2","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"Clarus Therapeutics Holdings, Inc.","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS JAMES E; THOMAS MCNERNEY & PARTNERS LP; TMP ASSOCIATES LP; TMP Associates II LP; TMP Nominee II, LLC; TMP Nominee, LLC; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2061685.0,"shares_display":"2,061,685","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":5216063.05,"total_display":"5,216,063.05","shares_owned_after":958989.0,"shares_owned_after_display":"958,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-25","scope":"insider"},{"id":9219197,"accession":"0001062993-22-010736","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-010736","line_url":"/filing/0001062993-22-010736#line-6","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"Clarus Therapeutics Holdings, Inc.","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS JAMES E; THOMAS MCNERNEY & PARTNERS LP; TMP ASSOCIATES LP; TMP Associates II LP; TMP Nominee II, LLC; TMP Nominee, LLC; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7585.0,"shares_display":"7,585","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":19190.05,"total_display":"19,190.05","shares_owned_after":3528.0,"shares_owned_after_display":"3,528","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-25","scope":"insider"},{"id":6769330,"accession":"0001062993-22-010622","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-22-010622","line_url":"/filing/0001062993-22-010622#line-6","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"CLARUS THERAPEUTICS INC","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners II L.P.; TMP Nominee, LLC; TMP ASSOCIATES LP; TMP Nominee II, LLC; THOMAS JAMES E; TMP Associates II LP; THOMAS MCNERNEY & PARTNERS LP; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2061685.0,"shares_display":"2,061,685","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":5216063.05,"total_display":"5,216,063.05","shares_owned_after":958989.0,"shares_owned_after_display":"958,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-21","scope":"insider"},{"id":6769328,"accession":"0001062993-22-010622","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-22-010622","line_url":"/filing/0001062993-22-010622#line-5","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"CLARUS THERAPEUTICS INC","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners II L.P.; TMP Nominee, LLC; TMP ASSOCIATES LP; TMP Nominee II, LLC; THOMAS JAMES E; TMP Associates II LP; THOMAS MCNERNEY & PARTNERS LP; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1663126.0,"shares_display":"1,663,126","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":4207708.78,"total_display":"4,207,708.78","shares_owned_after":773599.0,"shares_owned_after_display":"773,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-21","scope":"insider"},{"id":6769326,"accession":"0001062993-22-010622","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-22-010622","line_url":"/filing/0001062993-22-010622#line-4","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"CLARUS THERAPEUTICS INC","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners II L.P.; TMP Nominee, LLC; TMP ASSOCIATES LP; TMP Nominee II, LLC; THOMAS JAMES E; TMP Associates II LP; THOMAS MCNERNEY & PARTNERS LP; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13630.0,"shares_display":"13,630","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":34483.9,"total_display":"34,483.90","shares_owned_after":6340.0,"shares_owned_after_display":"6,340","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-21","scope":"insider"},{"id":6769325,"accession":"0001062993-22-010622","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-010622","line_url":"/filing/0001062993-22-010622#line-3","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"CLARUS THERAPEUTICS INC","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners II L.P.; TMP Nominee, LLC; TMP ASSOCIATES LP; TMP Nominee II, LLC; THOMAS JAMES E; TMP Associates II LP; THOMAS MCNERNEY & PARTNERS LP; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7585.0,"shares_display":"7,585","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":19190.05,"total_display":"19,190.05","shares_owned_after":3528.0,"shares_owned_after_display":"3,528","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-21","scope":"insider"},{"id":6769322,"accession":"0001062993-22-010622","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-010622","line_url":"/filing/0001062993-22-010622#line-2","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"CLARUS THERAPEUTICS INC","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners II L.P.; TMP Nominee, LLC; TMP ASSOCIATES LP; TMP Nominee II, LLC; THOMAS JAMES E; TMP Associates II LP; THOMAS MCNERNEY & PARTNERS LP; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5722.0,"shares_display":"5,722","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":14476.66,"total_display":"14,476.66","shares_owned_after":2661.0,"shares_owned_after_display":"2,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-21","scope":"insider"},{"id":6769319,"accession":"0001062993-22-010622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-010622","line_url":"/filing/0001062993-22-010622#line-1","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"CLARUS THERAPEUTICS INC","issuer_ticker":"CRXT","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"Thomas, McNerney & Partners II, LLC; Thomas, McNerney & Partners II L.P.; TMP Nominee, LLC; TMP ASSOCIATES LP; TMP Nominee II, LLC; THOMAS JAMES E; TMP Associates II LP; THOMAS MCNERNEY & PARTNERS LP; Thomas, McNerney & Partners, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1164.0,"shares_display":"1,164","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":2944.92,"total_display":"2,944.92","shares_owned_after":542.0,"shares_owned_after_display":"542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-21","scope":"insider"},{"id":8385207,"accession":"0001449374-15-000023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001449374-15-000023","line_url":"/filing/0001449374-15-000023#line-3","is_derivative":false,"issuer_cik":"0000764579","issuer_name":"CAS MEDICAL SYSTEMS INC","issuer_ticker":"CASM","issuer_name_source":null,"issuer_url":"/issuer/0000764579","owner_cik":null,"owner_name":"Thomas, McNerney & Partners II L.P.; TMP Nominee II, LLC; Thomas, McNerney & Partners II, LLC; TMP Associates II LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1591037.0,"shares_display":"1,591,037","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":2068348.1,"total_display":"2,068,348.10","shares_owned_after":1632945.0,"shares_owned_after_display":"1,632,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-13","scope":"insider"},{"id":8385204,"accession":"0001449374-15-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001449374-15-000023","line_url":"/filing/0001449374-15-000023#line-2","is_derivative":false,"issuer_cik":"0000764579","issuer_name":"CAS MEDICAL SYSTEMS INC","issuer_ticker":"CASM","issuer_name_source":null,"issuer_url":"/issuer/0000764579","owner_cik":null,"owner_name":"Thomas, McNerney & Partners II L.P.; TMP Nominee II, LLC; Thomas, McNerney & Partners II, LLC; TMP Associates II LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8025.0,"shares_display":"8,025","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":10432.5,"total_display":"10,432.50","shares_owned_after":8025.0,"shares_owned_after_display":"8,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-13","scope":"insider"},{"id":8385199,"accession":"0001449374-15-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001449374-15-000023","line_url":"/filing/0001449374-15-000023#line-1","is_derivative":false,"issuer_cik":"0000764579","issuer_name":"CAS MEDICAL SYSTEMS INC","issuer_ticker":"CASM","issuer_name_source":null,"issuer_url":"/issuer/0000764579","owner_cik":null,"owner_name":"Thomas, McNerney & Partners II L.P.; TMP Nominee II, LLC; Thomas, McNerney & Partners II, LLC; TMP Associates II LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5938.0,"shares_display":"5,938","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":7719.4,"total_display":"7,719.40","shares_owned_after":5938.0,"shares_owned_after_display":"5,938","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-13","scope":"insider"},{"id":8557978,"accession":"0001012975-15-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000075","line_url":"/filing/0001012975-15-000075#line-1","is_derivative":false,"issuer_cik":"0001369574","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001369574","owner_cik":null,"owner_name":"TMP Nominee II, LLC; TMP Associates II LP; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners II, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":730000.0,"shares_display":"730,000","price_per_share":53.11,"price_display":"53.11","price_state":"stated","total_value":38770300.0,"total_display":"38,770,300.00","shares_owned_after":4835731.0,"shares_owned_after_display":"4,835,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-28","filed_date":"2015-01-30","scope":"insider"},{"id":7054884,"accession":"0001209191-14-057156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-057156","line_url":"/filing/0001209191-14-057156#line-1","is_derivative":false,"issuer_cik":"0001369574","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001369574","owner_cik":null,"owner_name":"TMP Nominee II, LLC; Thomas, McNerney & Partners II L.P.; TMP Associates II LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12400.0,"shares_display":"12,400","price_per_share":20.598,"price_display":"20.60","price_state":"stated","total_value":255415.2,"total_display":"255,415.20","shares_owned_after":5220224.0,"shares_owned_after_display":"5,220,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-14","filed_date":"2014-09-09","scope":"insider"},{"id":7052381,"accession":"0001209191-14-009895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-009895","line_url":"/filing/0001209191-14-009895#line-2","is_derivative":false,"issuer_cik":"0001369574","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001369574","owner_cik":null,"owner_name":"TMP Nominee II, LLC; Thomas, McNerney & Partners II L.P.; TMP Associates II LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":83334.0,"shares_display":"83,334","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":1000008.0,"total_display":"1,000,008.00","shares_owned_after":5166785.0,"shares_owned_after_display":"5,166,785","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-12","scope":"insider"},{"id":7508384,"accession":"0001181431-10-058080","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001181431-10-058080","line_url":"/filing/0001181431-10-058080#line-9","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS JAMES E; TMP Nominee II, LLC; McNerney Pete; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners, LLC; Thomas, McNerney & Partners II, LLC; TMP Associates II LP; THOMAS MCNERNEY & PARTNERS LP; TMP Nominee, LLC; TMP ASSOCIATES LP","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":524229.0,"shares_display":"524,229","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":2096916.0,"total_display":"2,096,916.00","shares_owned_after":1407316.0,"shares_owned_after_display":"1,407,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-29","filed_date":"2010-11-30","scope":"insider"},{"id":7508382,"accession":"0001181431-10-058080","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-10-058080","line_url":"/filing/0001181431-10-058080#line-8","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS JAMES E; TMP Nominee II, LLC; McNerney Pete; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners, LLC; Thomas, McNerney & Partners II, LLC; TMP Associates II LP; THOMAS MCNERNEY & PARTNERS LP; TMP Nominee, LLC; TMP ASSOCIATES LP","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5476.0,"shares_display":"5,476","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":21904.0,"total_display":"21,904.00","shares_owned_after":14700.0,"shares_owned_after_display":"14,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-29","filed_date":"2010-11-30","scope":"insider"},{"id":7508380,"accession":"0001181431-10-058080","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-10-058080","line_url":"/filing/0001181431-10-058080#line-7","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS JAMES E; TMP Nominee II, LLC; McNerney Pete; Thomas, McNerney & Partners II L.P.; Thomas, McNerney & Partners, LLC; Thomas, McNerney & Partners II, LLC; TMP Associates II LP; THOMAS MCNERNEY & PARTNERS LP; TMP Nominee, LLC; TMP ASSOCIATES LP","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1967.0,"shares_display":"1,967","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":7868.0,"total_display":"7,868.00","shares_owned_after":5280.0,"shares_owned_after_display":"5,280","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-29","filed_date":"2010-11-30","scope":"insider"},{"id":7266098,"accession":"0001181431-10-058033","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001181431-10-058033","line_url":"/filing/0001181431-10-058033#line-12","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS MCNERNEY & PARTNERS LP; Thomas, McNerney & Partners, LLC; THOMAS JAMES E; Thomas, McNerney & Partners II, LLC; TMP Nominee, LLC; TMP ASSOCIATES LP; Thomas, McNerney & Partners II L.P.; TMP Associates II LP; TMP Nominee II, LLC; McNerney Pete","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":173399.0,"shares_display":"173,399","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":693596.0,"total_display":"693,596.00","shares_owned_after":1663193.0,"shares_owned_after_display":"1,663,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-29","filed_date":"2010-11-29","scope":"insider"},{"id":7266096,"accession":"0001181431-10-058033","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001181431-10-058033","line_url":"/filing/0001181431-10-058033#line-11","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS MCNERNEY & PARTNERS LP; Thomas, McNerney & Partners, LLC; THOMAS JAMES E; Thomas, McNerney & Partners II, LLC; TMP Nominee, LLC; TMP ASSOCIATES LP; Thomas, McNerney & Partners II L.P.; TMP Associates II LP; TMP Nominee II, LLC; McNerney Pete","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3178.0,"shares_display":"3,178","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":12712.0,"total_display":"12,712.00","shares_owned_after":56094.0,"shares_owned_after_display":"56,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-29","filed_date":"2010-11-29","scope":"insider"},{"id":7266094,"accession":"0001181431-10-058033","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-10-058033","line_url":"/filing/0001181431-10-058033#line-10","is_derivative":false,"issuer_cik":"0001204789","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001204789","owner_cik":null,"owner_name":"THOMAS MCNERNEY & PARTNERS LP; Thomas, McNerney & Partners, LLC; THOMAS JAMES E; Thomas, McNerney & Partners II, LLC; TMP Nominee, LLC; TMP ASSOCIATES LP; Thomas, McNerney & Partners II L.P.; TMP Associates II LP; TMP Nominee II, LLC; McNerney Pete","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":647.0,"shares_display":"647","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":2588.0,"total_display":"2,588.00","shares_owned_after":6297.0,"shares_owned_after_display":"6,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-29","filed_date":"2010-11-29","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001817944","name":"Clarus Therapeutics Holdings, Inc.","url":"/issuer/0001817944","role":"Ten percent owner","n_filings":1,"first_seen":"2022-04-25","last_seen":"2022-04-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001286162","name":"CLARUS THERAPEUTICS INC","url":"/issuer/0001286162","role":"Ten percent owner","n_filings":1,"first_seen":"2022-04-21","last_seen":"2022-04-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000764579","name":"CAS MEDICAL SYSTEMS INC","url":"/issuer/0000764579","role":"Ten percent owner","n_filings":1,"first_seen":"2015-02-13","last_seen":"2015-02-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001454189","name":"Auspex Pharmaceuticals, Inc.","url":"/issuer/0001454189","role":"Ten percent owner","n_filings":3,"first_seen":"2014-02-12","last_seen":"2015-01-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001375151","name":"ZOGENIX, INC.","url":"/issuer/0001375151","role":"Other","n_filings":2,"first_seen":"2010-11-29","last_seen":"2010-11-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001369574","retrieved_at":"2026-08-20T23:58:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}